New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 11, 2013
06:11 EDTMRMindray Medical upgraded to Buy from Neutral at Goldman
Goldman upgraded Mindray citing relative underperformance, strong China and emerging markets growth, and overdone earnings concerns. Price target is $39.60.
News For MR From The Last 14 Days
Check below for free stories on MR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 11, 2014
17:14 EDTMRMindray Medical sees FY14 revenue up 10% vs. FY13
The company now also anticipates its Fy14 non-GAAP net income to decrease by a mid-single-digit percentage over its FY13 non-GAAP net income. This guidance excludes the tax benefits related to the nationwide key software enterprise status and assumes a corporate income tax rate of 15% applicable to the Shenzhen subsidiary.
17:11 EDTMRMindray Medical reports Q2 EPS 54c, consensus 54c
Reports Q2 revenue $334.5M, consensus $348.3M.
15:32 EDTMRNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Ventas (VTR), consensus $1.09; Nuance Communications (NUAN), consensus 27c; Intercept Pharmaceuticals (ICPT), consensus (12c); Rackspace Hosting (RAX), consensus 16c; Opko Health (OPK), consensus (9c); Mindray Medical (MR), consensus 54c; Chimera Investment (CIM), consensus 9c; Globalstar (GSAT), one estimate (4c); 51job (JOBS), consensus 32c; Dealertrack Technologies (TRAK), consensus 373c; Caesars Entertainment (CZR), consensus ($1.19); Towerstream (TWER), consensus (10c); Resolute Energy (REN), consensus 1c; Forest Oil (FST), consensus (2c).

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use